Episodes of overtreatment during the first six months in children with congenital hypothyroidism and their relationships with sustained attention and inhibitory control at school age

Hormone Research in Paediatrics

Volumn 74, Issue 2, 2010, Pages 114-120

  Alvarez M ^a   Iglesias Fernandez C ^b   Rodriguez Sanchez A ^b   Dulin Iniguez E ^b   Rodriguez Arnao M D ^b  

^a UNIVERSITY OF HAVANA   (Cuba)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Congenital hypothyroidism; Endocrine control; Neurocognition

Indexed keywords

LEVOTHYROXINE;

ALERTNESS; ARTICLE; ATTENTION; CHILD; CLINICAL ARTICLE; COGNITION; CONGENITAL HYPOTHYROIDISM; DOSE RESPONSE; ENDOCRINE FUNCTION; FEMALE; GENDER; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT RESPONSE;

CHILD; CONGENITAL HYPOTHYROIDISM; DOSE-RESPONSE RELATIONSHIP, DRUG; EXECUTIVE FUNCTION; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INFANT; LINEAR MODELS; MALE; THYROTROPIN; THYROXINE;

EID: 77954802426     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000313370     Document Type: Article

References (47)

1. Álvarez MA, Guell R, Gonzalez J, Seuc A, Pérez H, Robaina R, Fernandez J: Neuropsychological development during the first two years in children with congenital hypothyroidism screened at birth: the Cuban experience. Screening 1992;1:167-173.
2. Rovet J, Álvarez MA: Attention and thyroid hormone in school age children with congenital hypothyroidism. J Child Psychol Psychiatry 1996;37:579-585.
3. Rovet J, Álvarez MA: Thyroid hormone and attention in children with congenital hypothyroidism. J Pediatr Endocrinol Metab 1996; 9:83-88.
4. Álvarez M, Guell R, Daniel L, Berazain AR, Machado C, Pascual A: Estado neurocognitivo en ninos de 8 anos con hipotiroidismo congenito tratado precozmente. Rev Neurol (Spain) 1999;28:701-706.
5. Álvarez Gonzalez MA, Carvajal Martinez F, Pérez Gesen C, Olivares Torres A, Fernandez-Yero JL, Robaina Álvarez R, Bencomo Gomez F, Fumero RA: Prognosis of cognition in congenital hypothyroidism following early treatment: double effect hypothesis. Rev Neurol (Spain) 2004;38:513-517.
6. Kooistra L, Vulsma T, van der Meere J: An investigation of impulsivity in children with early-treated congenital hypothyroidism. Dev Neuropsychol 2004;26:595-610.
7. Oerbeck B, Sundet K, Kase BF, Heyerdahl S: Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics 2003; 112: 923-930.
8. Kempers MJ, van der Sluijs Veer L, Nijhuis Van der Sanden RW, Lanting CI, Kooistra L, Wiedijk BM, Last BF, de Vijlder JJ, Grootenhuis MA, Vulsma T: Neonatal screening for congenital hypothyroidism in the Netherlands: cognitive and motor outcome at 10 years of age. J Clin Endocrinol Metab 2007; 92: 919-924.
9. Oerbeck B, Reinvang I, Sundet K, Heyerdahl S: Young adults with severe congenital hypothyroidism: cognitive event related potentials (ERPs) and the significance of an early start of thyroxine treatment. Scand J Psychol 2007;48:61-67.
10. Sastre-Riba S: Early development and learning conditions: the role of the executive functions. Rev Neurol (Spain) 2006; 13:S143-S151.
11. Tillotson SL, et al: Relation between biochemical severity and intelligence in early treated congenital hypothyroidism: a threshold effect. Br Med J 1994; 13:440-445.
12. Rovet J: Children with congenital hypothyroidism and their siblings: do they really differ? Pediatrics 2005;115:52-57.
13. Olivares A, Pérez G, Carvajal F, Pérez MC, Galan L, Álvarez M: Differential cognitive pattern in patients with congenital hypothyroidism according to etiology: dyshormonogenesis and dysembryogenesis. Clin Neurophysiol 2008; 119:54.
14. Selva KA, Harper A, Downs A, Blasco PA, LaFranchi SH: Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr 2005; 147: 775780.
15. Heyerdahl S, Oerbeck B: Congenital hypothyroidism: developmental outcome in relation to levothyroxine treatment variables. Thyroid 2003;13:1029-1038.
16. Delvecchio M, Faienza MF, Acquafredda A, Zecchino C, Peruzzi S, Cavallo L: Longitudinal assessment of levo-thyroxine therapy for congenital hypothyroidism: relationship with aetiology, bone maturation and biochemical features. Horm Res 2007;68:105-112.
17. Bongers-Schokking JJ, de Muinck Keizer- Schrama SM: Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism. J Pediatr 2005;147:768-774.
18. Salerno M, Militerni R, Bravaccio C, Micillo M, Capalbo D, Di MS, Tenore A: Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism. Thyroid 2002;12:45-52.
19. Dimitropoulos A, Molinari L, Etter K, Torresani T, Lang-Muritano M, Jenni OG, Largo RH, Latal B: Children with congenital hypothyroidism: long-term intellectual outcome after early high-dose treatment. Pediatr Res 2009;65: 242-248.
20. Boileau P, Bain P, Rives S, Toublanc JE: Earlier onset of treatment or increment in LT4 dose in screened congenital hypothyroidism: which is the more important factor for IQ at 7 years? Horm Res 2004;61:228-233.
21. Simoneau-Roy J, Marti S, Deal C, Huot C, Robaey P, Van Vliet G: Cognition and behavior at school entry in children with congenital hypothyroidism treated early with highdose levothyroxine. J Pediatr 2004; 144: 698-700.
22. Marti S, Álvarez M, Simoneau-Roy J, Leroux S, Van Vliet G, Robaey P: Effects of early high-dose levothyroxine treatment on auditory brain event-related potentials at school entry in children with congenital hypothyroidism. Horm Res 2006; 66:240-248.
23. Rose SR, Brown RS: Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006; 117: 2290-2302.
24. Ng SM, Anand D, Weindling AM: High versus low dose of initial thyroid hormone replacement for congenital hypothyroidism. Cochrane Database Syst Rev 2009; 21:CD006972.
25. Posner MI, Duhaene S: Attentional networks. Trend Neurosci 1994;17:75-79.
26. Raz A: Anatomy of attentional networks. Anat Rec [B] New Anat 2004;281:21-36.
27. Rueda R, Fan J, McCandliss BD, Halparin J, Gruber D, Pappert L, Posner M: Development of attentional networks in childhood. Neuropsicologia 2004;42:1029-1040.
28. Burgess PW, Alderman N, Forbes C, Costello A, Coates LM, Dawson DR, Anderson ND, Gilbert SJ, Dumontheil I, Channon SJ: The case for the development and use of 'ecologically valid' measures of executive function in experimental and clinical neuropsychology. Int Neuropsychol Soc 2006; 12:194-209.
29. Kawachi Y, Gyoba J: A new response-time measure of object persistence in the tunnel effect. Acta Psychol 2006;123:73-90.
30. Sheese BE, Rothbart MK, Posner MI, White LK, Fraundorf SH: Executive attention and self regulation in infancy. Infant Behav Dev 2008;31: 501-510.
31. Fan J, Hof PJ, Worden MS, Guise KG, McCandliss BD, Fossella J, Posner MI: The functional integration of the anterior cingulate cortex during conflict processing. Cerebral Cortex 2008;18:796-805.
32. Posner MI: Evolution and Development of Self-Regulation. 77th Arthur Lecture on Human Brain Evolution. New York, American Museum of Natural History, 2008.
33. MacDonald AW 3rd: Building a clinically relevant cognitive task: case study of the AX paradigm. Schizophr Bull 2008;4:619-628.
34. Watanabe K, Sato TR, Shimojo S: Perceived shifts of flashed stimuli by visible and invisible object motion. Perception 2003;32: 545559.
35. UK Newborn Screening Programme Centre: Newborn blood spot screening in the UK: Policies and standards, April 2005 (http:// newbornscreening-bloodspot. org.uk).
36. Rodriguez Arnao MD, Rodriguez Sanchez A, Pose Cabarcos AF, Rodriguez Arnao J: Tratamiento del hipotiroidismo. An Esp Pediatr 2002;56:53-61.
37. Toga AW, Thompson PM, Sowell ER: Mapping brain maturation. Trend Neurosci 2009;29:148-159.
38. Lenroot RK, Giedd JN: Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neurosci Biobehav Rev 2006;30:718-719.
39. Zoeller RT, Rovet J: Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol 2004; 16:809-818.
40. Santisteban P, Bernal J: Thyroid development and effect on the nervous system. Rev Endocr Metab Disord 2005;6:217-228.
41. Bernal J: Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab 2007;3:249-259.
42. Gruters A, Krude H, Biebermann H: Molecular genetic defects in congenital hypothyroidism. Eur J Endocrinol 2004; 151(suppl 3):U39-U44.
43. Dong H, Wade M, Williams A, Lee A, Douglas GR, Yauk C: Molecular insight into the effects of hypothyroidism on the developing cerebellum. Biochem Biophys Res Commun 2005; 20:1182-1193.
44. Ahmed OM, El-Gareib AW, El-Bakry AM, Abd El-Tawab SM, Ahmed RG: Thyroid hormones states and brain development interactions. Int J Dev Neurosci 2008;26:825-826.
45. Olson IR, Gatenby JC, Leung HC, Skudlarski P, Gore JC: Neuronal representation of occluded objects in the human brain. Neuropsychologia 2004;42:95-104.
46. Álvarez M, Carvajal F, Renón A, Pérez C, Olivares A, Rodriguez G, Álvarez V: Differential neurocognitive pattern of severity of disease and treatment variables in children with congenital hypothyroidism. Horm Res 2004; 61:17-20.
47. LaFranchi SH: Should the levothyroxine starting dose be tailored to disease severity in neonates with congenital hypothyroidism? Nat Clin Pract Endocrinol Metab 2008; 4:658-659.